ProQR Therapeutics BV (PRQR) — Cash Flow Reinvestment Rate
ProQR Therapeutics BV (PRQR) has a Cash Flow Reinvestment Rate of 0.01x as of March 2023, reinvesting $225.00K (capex $136.00K plus investments $-89.00K) from operating cash flow of $44.73 Million. See ProQR Therapeutics BV free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ProQR Therapeutics BV Cash Flow Reinvestment Rate (2023–2023)
Historical reinvestment intensity for ProQR Therapeutics BV across 1 annual periods. For the full cash flow conversion analysis, see ProQR Therapeutics BV cash flow conversion.
Annual Cash Flow Reinvestment Rate for ProQR Therapeutics BV (2023–2023)
Year-by-year capital reinvestment analysis for ProQR Therapeutics BV. See PRQR free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.26x | $5.65 Million | $21.55 Million | $1.37 Million | — |